Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−10.19 MUSD
585.20 KUSD
242.45 M
About E-THERAPEUTICS PLC
Sector
Industry
CEO
Ahmad Ali Mortazavi
Website
Headquarters
London
Founded
2001
ISIN
GB00B2823H99
FIGI
BBG00DJ2HKL0
e-Therapeutics Plc, is a drug discovery and development company, which engages in the provision of evaluation services to investors and pharmaceutical companies. The company focuses on the therapeutic immune-oncology, addressing drug resistance in targeted cancer therapies and antivirals. It offers the following variety of preclinical stage assets: ETS2300, telomerase inhibition in anti-cancer; ETS3100, small molecule anti-TNFa; ETS2400, Hedgehog pathway inhibition; and ETS5200, broad spectrum antivirals together with two immuno-oncology checkpoint projects. The company was founded by Malcolm Philip Young on October 15, 2001 and is headquartered in London, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ETXPF is 0.1300 USD — it has decreased by 7.14% in the past 24 hours. Watch E-Therapeutics PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange E-Therapeutics PLC stocks are traded under the ticker ETXPF.
E-Therapeutics PLC is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
ETXPF stock is 7.69% volatile and has beta coefficient of −2.15. Track E-Therapeutics PLC stock price on the chart and check out the list of the most volatile stocks — is E-Therapeutics PLC there?
Yes, you can track E-Therapeutics PLC financials in yearly and quarterly reports right on TradingView.
Today E-Therapeutics PLC has the market capitalization of 65.83 M, it has decreased by 15.97% over the last week.
No, ETXPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ETXPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade E-Therapeutics PLC stock right from TradingView charts — choose your broker and connect to your account.
ETXPF reached its all-time high on Nov 18, 2021 with the price of 0.6125 USD, and its all-time low was 0.1300 USD and was reached on Nov 29, 2023. View more price dynamics on ETXPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So E-Therapeutics PLC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating E-Therapeutics PLC stock shows the sell signal. See more of E-Therapeutics PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.